• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Anixa Biosciences Inc (NQ: ANIX )

    3.770 +0.520 (+16.00%)
    Streaming Delayed Price Updated: 12:11 PM EDT, Oct 28, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Anixa Biosciences Inc

    < Previous 1 2 Next >
    Anixa Biosciences And 3 Other Stocks Under $5 Insiders Are Buying
    Via Benzinga
    EXCLUSIVE: FDA Approves Anixa Biosciences' Individual Patient Trial Application For Ovarian Cancer CAR-T Therapy
    FDA Approves Anixa Biosciences' Ovarian Cancer CAR-T Therapy for Individual Patient Trial. Moffit Cancer Center receives approval for a second dose in an ongoing Phase I trial showing early promising... 
    Via Benzinga
    Exposures Product Safety
    EXCLUSIVE: Anixa Biosciences Finds Stock Undervalued, Launches $5M Stock Buyback Program
    Anixa Biosciences announces $5 million share repurchase program due to undervalued stock. Partnership with Cleveland Clinic for cancer vaccines. 
    Via Benzinga
    ANIX Stock Earnings: Anixa Biosciences Beats EPS for Q2 2024
    ANIX stock results show that Anixa Biosciences beat analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    7 Penny Biotech Stocks to Triple Your Investment
    Biotech penny stocks offer the chance to triple your investments and require an appetite for risk in order to capture returns. 
    Via InvestorPlace
    Recap: Anixa Biosciences Q1 Earnings
    Via Benzinga
    6 Analysts Have This to Say About Anixa Biosciences
    Via Benzinga
    The Latest Analyst Ratings for Anixa Biosciences
    Via Benzinga
    Expert Ratings for Anixa Biosciences
    Via Benzinga
    Anixa Biosciences, Inc. (NASDAQ: ANIX) Featured in Coverage of the EF Hutton Annual Global Conference
    Via Investor Brand Network
    Sidoti Events, LLC's Virtual May Micro-Cap Conference
    Via ACCESSWIRE
    Anixa Biosciences (NASDAQ:ANIX) Gains Attention for Its Innovative Cancer Therapies Amid Biopharma Sector Growth
    Via AB Newswire
    Sidoti Events, LLC's Virtual January Micro-Cap Conference
    Via ACCESSWIRE
    Anixa Biosciences, A New Type Of Biotech Company: Could It Disrupt The Cancer Landscape?
    Anixa Biosciences (NASDAQ: ANIX) is an interesting, undiscovered biotech company that seeks to disrupt the cancer landscape by working with some highly credible partners. The company is undiscovered... 
    Via Benzinga
    3 Biotech Stocks to Turn $5,000 Into $1 Million: December 2023
    Some of the most explosive opportunities can be found in biotech stocks. In fact, as we head into New Year 2024, here are three to consider. 
    Via InvestorPlace
    Anixa Biosciences Reveals Updated Data From Breast Cancer Vaccine Trial, Says 'Exceeded Expectations'
    Anixa Biosciences Inc (NASDAQ: ANIX) announced new and updated results from the Phase 1 trial of its breast cancer vaccine.  
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    The 3 Most Undervalued Cheap Stocks to Buy in September 2023
    These cheap stocks to buy are the ones for long term growth and high returns in your investment portfolio. 
    Via InvestorPlace
    Could Anixa Biosciences (NASDAQ:ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer?
    Via ACCESSWIRE
    Could Anixa Biosciences (NASDAQ: ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer?
    Cancer is a disease that affects millions of people around the world. Historically, cancer vaccines have not been very successful in treating or preventing the disease. However, recent research on the... 
    Via Benzinga
    Anixa Biosciences And 2 Other Penny Stocks Insiders Are Aggressively Buying
    The Dow Jones edged higher on Friday, recording gains for the tenth straight session. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects.... 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Appreciating The Passing Of A Titan & Incorporating Alternative Data Signals
    Kathleen Moriarty, the lawyer who helped develop the structure for SPY and a true co-founder of the ETF industry, passed away last week. 
    Via Talk Markets
    Benzinga's Top Ratings Upgrades, Downgrades For December 23, 2022
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Gainers Reshape Lifesciences (NASDAQ:RSLS) shares increased by 12.7% to $0.34 during Monday's after-market session. The market value of their outstanding shares is at $1.2 million. 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
      
    Via Benzinga
    Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday
    Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday. 
    Via Benzinga
    Recap Of Monday's Biotech Catalysts - End Of the Day Summary
    Via Benzinga
    Anixa Initiates Patient Dosing in Initial-Stage Ovarian Cancer Study
    Anixa Biosciences (NASDAQ: ANIX) commenced treatment of the first patient in the clinical trial of its novel chimeric antigen receptor T-cell (CAR-T) therapy for ovarian cancer. 
    Via Benzinga
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.